JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) provides its current outlook for non-GAAP financial performance for the year ending December 31, 2015.
In an effort to enhance investor understanding of the Company’s business performance, and to provide more clarity and transparency regarding its projections for 2015, the following assumptions will apply to the 2015 non-GAAP financial outlook:
• Compared to 2014, foreign exchange rate fluctuations are expected to have a $700 million adverse impact on revenues, while reducing operating income by a modest $60-70 million;
Help employers find you! Check out all the jobs and post your resume.
